Analysis of the antibodies induced by UBAC® vaccination

Home Knowledge Analysis of the antibodies induced by UBAC® vaccination

Analysis of the antibodies induced by UBAC® vaccination

The aim of the present study was to evaluate the antibody response against UBAC® vaccine antigen, the Bio­lm Adhesion Component (BAC), with different adjuvants. Moreover, the ability of the generated antibodies to inhibit bio­lm formation and to recognize different Streptococcus uberis strains was evaluated in vitro.

About this article

Appeared in

National Mastitis Council, 2018

Date

Jun 11, 2018

Authors

Collado, R.; Solà, C.; Martín, R.; Roca, M.; Prenafeta, A.

Summary

The adjuvant of the UBAC® vaccine (Hipramune®U) induced the greatest antibody levels against BAC antigen compared with other tested adjuvants. Moreover, these antibodies had the ability to reduce the S. uberis biolm formation in vitro and to recognize heterologous strains of S. uberis, in terms of geographical origin or in vitro biolm formation ability.

Related products

Share this on